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Abstract
Introduction
Hypertonic media causes cells to shrink due to water loss through aquaporin channels.
After acute shrinkage, cells either regulate their volume or, alternatively, undergo a number
of metabolic changes which ultimately lead to cell death. In many cell types, hypertonic
shrinkage is followed by apoptosis. Due to the complex 3D morphology of skeletal muscle
and the difficulty in obtaining isolated human tissue, we have begun skeletal muscle volume
regulation studies using the human skeletal muscle cell line TE671RD. In this study we in-
vestigated whether hypertonic challenge of the human skeletal muscle cell line TE671RD
triggered cell death or evoked a cell volume recovery response.
Methods
The cellular volume of TE671RD cells was calculated from the 2D surface area. Cell death
was assessed by both the trypan blue live/dead assay and the TUNEL assay.
Results
Medium osmolality was increased by addition of up to 200mM sucrose. Addition of 200mM
sucrose resulted in mean cell shrinkage of 44±1% after 30mins. At later time points (2 and 4
hrs) two separate cell subpopulations with differing mean cell volume became apparent.
The first subpopulation (15±2% of the total cell number) continued to shrink whereas the
second subpopulation had an increased cell volume. Cell death was observed in a small
proportion of cells (approximately 6-8%).
Conclusion
We have established that a substantial proportion of TE671RD cells respond to hypertonic
challenge with RVI, but that these cells are resistant to hypertonicity triggered cell death.
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Introduction
Regulatory volume increase (RVI) and apoptotic volume decrease (AVD) are two opposing cel-
lular volume-regulatory mechanisms [1–3]. The first of these, RVI, is frequently involved with
adaptation to hypertonic media and cell survival, whilst in some cells, but not others AVD
leads to cell death [4, 5]. Frequently after cells reach a certain critical threshold of shrinkage,
cells then undergo RVI or AVD. Hypertonic challenge can lead to apoptosis in a number of cell
types [6–10]. In this study we investigate whether hypertonic challenge induces cell death in a
human derived skeletal muscle cell line TE671RD.
Overall control of systemic osmolality is affected by a number of periventricular osmosen-
sing structures within the brain [11] and involves osmotic response of individual neurones by
mechanisms analogous to that of cell volume regulation itself [12]. Older people have an ap-
proximately 3% (302.2 compared with 291.2 mOsm/Kg H2O) increased plasma osmolality
compared to healthy younger people [13]. This could be due to changes in kidney function, as
a result of hypertension, or due to environmental factors such as diet. However, a loss in os-
motic response is also observed in the elderly, suggesting that an issue with osmotic control
could result in increased plasma osmolality [14, 15]. Cells are generally able to withstand small
(2–3%) changes in tissue osmolality, but beyond this the activation of volume defence mecha-
nisms becomes necessary [16]. Such chronic change in plasma osmotic potential of older peo-
ple could therefore have a negative impact on skeletal muscle physiology, affecting such
parameters as cellular volume. Indeed, a number of genes critical to both cell volume control
and apoptosis, including the AQP2 and AQP3 aquaporin channels, are differentially expressed
in ageing skeletal muscle [17]. The importance of apoptosis to ageing skeletal muscle physiolo-
gy is controversial. It has been argued that apoptosis is not necessarily pathological and is im-
portant for the process of remodelling [18], but it is increased subtly during ageing [19]. It has
therefore been hypothesised that apoptosis may contribute to sarcopenia in older people [19–
22], potentially resulting from mitochondrial dysregulation [23]. Different skeletal muscle fibre
types have been shown to have differing propensity to undergo apoptosis in response to TNFα
[24], but apoptosis in response to hypertonic challenge has not previously been investigated.
TE671RD cells are potentially an ideal model for cell volume regulation experiments because
whilst they derive from human skeletal muscle they readily round-up and facilitate volume
measurement. There is no evidence for the presence of t-tubules in TE671RD cells, structures
which would naturally confound simple geometric estimation of cellular volume in native skel-
etal muscle fibres. The literature shows that TE671RD cells express the skeletal muscle specific
form of the nicotinic acetylcholine receptor [25] and TTX-resistant voltage-gated sodium
channels characteristic of native skeletal muscle [26]. Another ion channel, however, the KATP
channel is not pharmacologically identical in TE671RD cells [27] to that found in our own rat
skeletal muscle studies [28]. It should be noted, however, that most skeletal muscle ion channel
studies use rodent or amphibian tissue rather than human and so species is a confounding vari-
able. Aside from muscle ion channel expression, a recent study showed the expression of striat-
ed muscle developmental micro mRNA mir206 in TE671RD cells [29–31], but there have been
few studies of other muscle like properties such as expression of contractile apparatus. There
are also very limited data available on their volume regulation.
In this study we analysed whether severe hypertonic challenge triggers RVI and/or cell
death in TE671RD. We find that whilst there is a consistent reduction in cell volume in re-
sponse to hypertonic challenge and strong evidence of RVI very little cell death occurs and it
does not seem likely that this will contribute to any loss of motor units in the elderly.
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Methods
Culture
TE671RD cells constitute a human rhabdomyosarcoma cell line showing features of skeletal
muscle differentiation [32, 33]. These were a kind gift from the group of Prof Vincent (Oxford
University, [34]). TE671RD cells were maintained in 300mOsm/Kg H2O DMEM (GIBCO
31885, Life Technologies Ltd, Paisley, UK) medium with 10% fetal calf serum, 1% amphoteri-
cin B and 2% penicillin and streptomycin at 37°C and 5% CO2. All reagents were obtained
from Sigma-Aldrich (UK) unless otherwise stated.
Measurement of cell size
Cells were detached from the flask surface by 0.25% Trypsin-EDTA solution. A pellet was
formed by centrifugation of the cell solution (300 x g, 5 min) (MultifugeX1, Thermo Fisher Sci-
entific) and supernatant removed. Cells were then re-suspended in culture media with FCS and
incubated for 1 hour at 37°C and 5% CO2 before the experiment. We measured cell shrinkage
upon exposure to hypertonic media with a wide range of sucrose concentrations (0–200 mM).
Osmolality was measured using a freezing point micro-osmometer (3MO, Advanced Instru-
ments, Norwood, USA). We compared cell volume in isotonic control and hypertonic samples
using light microscopy with an Olympus IX51 equipped with a JVC TK-C921EG digital cam-
era. Cell volume was calculated as described previously [35] from the 2D areas with ImageJ
software [36].
Cell viability
Cell viability was assessed with the trypan blue exclusion assay. DNA fragmentation character-
istic of apoptotic programmed cell death was detected with the terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP nick end labelling (TUNEL) assay [37] using the Trevigen
apoptotic cell system (TACS) TACS 2 TdT-Fluor Apoptosis Detection Kit (Trevigen, Gaithers-
burg, MD, USA). Control and sucrose treated cells were fixed in 10% neutral buffer formalin
(NBF), placed onto slides and then processed according to the manufacturer’s instructions.
After staining, slides were mounted with DAPI enriched VECTASHIELD Mounting Medium.
Statistical analysis was carried out using the non-parametric Mann-Whitney test (p 0.05) in
MiniTab (Minitab Ltd., Coventry, UK).
Results
Under iso-osmotic control conditions (300 mOsm/Kg H2O) mean TE671RD cell volume was
2840±22μm3 (n = 200, Fig 1). Following 30 minutes incubation with sucrose (0 to 200mM),
volume decreased to close to that predicted from “ideal osmotic behaviour” [38] (Fig 1). We
then went on to measure cell volume at a series of time points (0.5, 2 and 4hr) following expo-
sure to 200mM sucrose. We measured cell volume in between 100 and 200 cells in each of 13
separate experiments. Initially volume fell to 44±1% (n = 13, t = 0.5hr). By 2hrs cells had clus-
tered into two distinct populations (assessed by cellular volume). Those cells identified in the
first population reduced in size, whereas cells of the second population significantly increased
in cellular volume (Fig 2). At 2hr 18±1% (n = 8) of cells had increased their volume (I.e., exhib-
ited RVI) and this rose to 21±1% (n = 6) of cells at 4hr.
Cell shrinkage can be a trigger for apoptosis in many cell types and so we investigated hy-
pertonicity evoked changes in cell viability and DNA fragmentation (an indicator of apoptotic
programmed cell death) using the trypan blue exclusion assay and TUNEL assay respectively.
We found an increase of dead cell count after prolonged incubation with 200 mM sucrose; the
An In VitroModel of Skeletal Muscle Volume Regulation
PLOS ONE | DOI:10.1371/journal.pone.0127889 June 1, 2015 3 / 11
Fig 1. Volume of TE671RD following 30 min of increased osmolality. (A) Cells measured in 300mOsm/Kg H2O (no sucrose), (B) with 350 mOsm/Kg H2O
(50 mM sucrose), (C) with 400 mOsm/Kg H2O (100mM sucrose) (D) with 450 mOsm/Kg H2O (150mM sucrose), (E) with 500 mOsm/Kg H2O (200mM
sucrose). For (A) to (E) smooth lines are Gaussian fits. (F) Normalised volume against sucrose concentration. The smooth line is drawn to that of ideal
osmotic behaviour: Vol/Vol0 = V0 * osm0/osmsucrose. Where Volo and Vol are the initial volume and the volume attained by the cells in the sucrose containing
solution (measured at 30mins). osm0 is the initial osmolality of the solution (I.e., DMEM alone, 300mOsm/Kg H2O) and osmsucrose is the osmolality once
sucrose had been added (i.e., 300mOsm/Kg H2O + [sucrose]).
doi:10.1371/journal.pone.0127889.g001
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Fig 2. Differential volume defencemechanisms within TE671RD populations. Following prolonged exposure to 200mM sucrose (osmolality 500mOsm/
Kg H2O), two populations of cells were distinguishable. (A) Illustrates one experiment when cells have been exposed to 200mM sucrose (osmolality
500mOsm/Kg H2O) for 2hrs. Two populations are clearly apparent. The blue line illustrates a 2 component Gaussian fit to the data with smaller and larger
components indicated by red and black lines respectively. (B) Data from between 6 and 13 experiments similar to that illustrated in (A). The first population
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percentage of dead cells after 2hr and 4hr incubation with 200 mM sucrose was 1.5 and 1.9 fold
higher (respectively) than in control samples (Fig 3). These changes were statistically increased
from control, but there was no significance between the two time points of 2 and 4 hr. The
DNA fragmentation fluorescent microscopy assay showed that after 4hr hypertonic exposure
(200mM sucrose) 6±1% (n = 5) of cells had a bright green nucleus with condensed chromatin,
consistent with the development of DNA fragmentation.
Discussion
In this report we investigated whether hypertonic challenge triggers cell death and/or regulato-
ry volume increase (RVI) in the human skeletal muscle cell line, TE671RD. We found that a
significant proportion of cells underwent RVI and there was minimal resultant cell death even
with very high osmotic challenge. Initial shrinkage very closely fitted that expected from the
“ideal osmotic shrinkage” described in native skeletal muscle fibres by Blink et al [38] and Fer-
enczi et al [39]. Blink et al [38] saw little evidence of RVI and Ferenczi et al [39] reported only
a few percent RVI. In contrast, Lindinger et al saw significant and rapid RVI in mouse soleus
(slow twitch) skeletal muscle [40]. We find that the TE671RD population divides in to subpop-
ulations with and without significant RVI capacity in a similar way to that we reported previ-
ously for leukaemia U937 cells [2].
Apoptosis is a stereotyped form of programmed cell death which includes a number of mor-
phological and biochemical changes including DNA fragmentation [41]. The degree of in-
creased osmolality in older people is relatively small (3%) [13], compared with the challenge
we applied here of up to 200mOsm/Kg H20, but in our assays only a small proportion of cells
showed evidence of DNA fragmentation. We would therefore tend to exclude increased osmo-
lality as a potential trigger for apoptosis and sarcopenia in ageing people. It should be noted,
however, that we applied a high osmolality solution for only a few hours, whilst naturally, peo-
ple would have their small elevation in plasma osmolality for many years. The osmolalities we
used here were quite extreme; (DMEM plus added sucrose) varied between 300 and
500mOsm/Kg H2O. It was shown in rabbit studies that 400mOsm/Kg H2O and above results
in severe clinical symptoms, and most animals died by 450mOsm/Kg H2O [42].
One particular point of note in the present study is the apparently slow rate of shrinkage,
with minimum volume being measured at a time of 2hrs following hypertonic challenge. There
are several points surrounding this. The first is that since our protocol was to measure at 0.5
hrs and then again at 2 hrs, it is entirely possible that the minimum volume was actually
reached well before 2 hrs. The reason for this is that our experimental design was not intended
to demonstrate the kinetic properties and follow progression of individual cells (as we have
done in some other studies), but to follow populations of cells. Some cells trigger RVI earlier,
and some later (some not at all), but we felt that by 2 hrs all cells that were going to undergo
RVI would have begun to do so. We caution against kinetic interpretation of our data, however,
since the study simply was not designed for that. A more interesting hypothesis is that these
cells have very few aquaporin channels and very low water permeability. We will investigate
this in the future. From a biological/biochemical perspective it is interesting to note that the
rate of attaining a new cellular volume following change of solution osmolality is dependent
upon cell water permeability. This can be at least 10 fold different between different types of
cells and is greatly affected by the composition of the extracellular solution [43]. In cases where
similarly slow rates of cellular shrinkage have been observed [2, 43, 44], the extracellular
continued to shrink (red circles); the second population of cells (black squares) maintained or increased volume. At 2 hrs 15±2% (n = 9) of cells are included
in the smaller population, at 4hrs 17±2% (n = 7) are included in the smaller population.
doi:10.1371/journal.pone.0127889.g002
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Fig 3. Cell viability assays. (A) Example of the live/dead trypan blue exclusion assay. Cells are shown in control and then during 0.5h-4h incubation in
hypertonic media with 200 mM/Kg H2O sucrose (from left to right). (B)Quantification of the live/dead trypan blue exclusion assay with time. Cell death with
200mM sucrose at 2hrs and 4hrs was statistically increased from control (p<0.05, Mann-Whitney), but there was no statistical difference between 2hrs and
4hrs. (C) Fluorescent images of TE671RD cells stained by DAPI (blue) and TACS 2 TdT-fluor “Apoptosis Detection Kit” (green) obtained using Nikon Eclipse
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osmolality was also increased by sucrose (similar to our own study) which seems to decrease
cell permeability [43]. One might speculate this could involve block of aquaporin channels by
sucrose, but we are not aware if this has been investigated directly. Yurinskaya et al [2] show
comparative shrinkage to be much faster in the presence of elevated NaCl compared to sucrose
and the rapid skeletal muscle shrinkage observed by [40] used addition of NaCl. Whilst the
aquaporin composition of skeletal muscle varies with age [17], the predominant isoform is
AQP4 [45] and further pharmacological analysis of this and other aquaporins would be useful.
Finally, it is possible that following passive shrinkage, a degree of active volume shrinkage then
takes place; the mechanism of which would be beyond the scope of the current manuscript.
This could be some sort of “dying cell volume decrease” (DVD) as seem in many [4, 5], but not
all cell types [4, 46]. Since we did not see a great deal of cell death itself, even at 4 hrs, this
seems unlikely. We found that a rather high proportion of cells lacked RVI, but few cells ap-
peared to initiate apoptosis and so our data does not support a notion that hypertonic shrink-
age and lack of RVI directly correlates to induction of apoptosis. This does not directly shed
light on the debate as to whether shrinkage is a necessary step for apoptosis in this cell line,
however [4, 5], since there was so little evidence of apoptosis itself.
The present study used a human skeletal muscle derived cell line, TE671RD. Previously,
TE671RD cells have been used mainly for investigation of the human nicotinic receptor physi-
ology [33], but we will continue to investigate its volume regulatory properties in parallel with
other in vitro skeletal muscle systems. Myoblasts formed from freshly isolated rodent tissue
would be an alternative skeletal muscle cell volume model and it would be interesting to com-
pare the volume regulatory properties of human TE671RD cells to such cell lines as the rat L6
or mouse C2C12. The attraction to us of TE671RD cells is that they constitute a human skeletal
muscle derived cell line and thus express human muscle isoforms of important muscle recep-
tors such as the nicotinic acetylcholine receptor [25]. There is unlikely to be a single perfect in
vitromodel of skeletal muscle cell volume control. For example, in the introduction to this
manuscript we discuss known similarities and differences between native skeletal muscle and
TE671RD cells, but it is also likely that ion channel expression is dissimilar between different
skeletal muscle fibre types within the same species. In terms of volume regulation, TE671RD
cells form round cells and allow for the measurement of cellular volume from 2D surface area
in a way difficult to reproduce with freshly dissociated skeletal muscle, but possible with the ro-
dent myoblasts. The clear limitation is the differences we have observed (above) between
TE671RD cells and previously reported native skeletal muscle. In future studies we will contin-
ue to investigate the cellular machinery of skeletal muscle cellular volume control, both in
terms of its regulatory volume increases and decreases. Furthermore, we will explore apoptosis
in this cell line and investigate responses to inflammatory cytokines known to be important for
skeletal muscle senescence. This work may prove useful, not just in the study of ageing, but
also in the disease most closely thought to involve skeletal muscle cellular volume control;
compartment syndrome.
In conclusion, we found that the human skeletal muscle cell line, TE671RD exhibits greater
active cell volume regulation than reported for some native skeletal muscle and the cells are
very resistant to hypertonicity triggered cell death. If these effects were reproduced in native
human skeletal muscle it would strongly suggest that the relatively modest plasma hypertonici-
ty measured in older people is not likely to contribute to cell death or sarcopenia.
microscope. Fluorescent microscopy showed the presence of DNA fragmentation after 4 h of 200 mM sucrose incubation. 6±1% (n = 5) of sucrose-treated
cells demonstrated a bright green nucleus with condensed chromatin. The TUNEL apoptosis assay was conducted at 4hrs.
doi:10.1371/journal.pone.0127889.g003
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